4//SEC Filing
Nolan Garry Ph.D. 4
Accession 0001104659-22-068065
CIK 0001711933other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:02 PM ET
Size
6.1 KB
Accession
0001104659-22-068065
Insider Transaction Report
Form 4
Nolan Garry Ph.D.
Director
Transactions
- Award
Stock Option (Right to Buy
2022-06-01+30,549→ 30,549 totalExercise: $11.24Exp: 2032-06-01→ Common Stock (30,549 underlying)
Holdings
- 655,084
Common Stock
Footnotes (1)
- [F1]Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 1, 2023, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant.
Documents
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001857405
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:02 PM ET
- Size
- 6.1 KB